Antihypertensive medications and cancer risk: Evidence from 0.27 million patients with newly diagnosed hypertension
BackgroundWhether specific antihypertensive treatments increase cancer risk in patients with hypertension is still controversial. We aimed to estimate the associations of different antihypertensive treatments with cancer risk in real-world settings.MethodsA longitudinal cohort study was designed in...
Saved in:
Main Authors: | Huan Yu, Zhike Liu, Yiqun Wu, Liuyan Zheng, Kun Wang, Jingxian Wu, Huairong Wang, Kexin Ding, Ruotong Yang, Huziwei Zhou, Feng Sun, Yonghua Hu, Hongbo Lin, Peng Shen, Siyan Zhan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1559604/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
No increased risk of intussusception after pentavalent rotavirus vaccination in China: a retrospective birth cohort using electronic health records of Ningbo city
by: Zhike Liu, et al.
Published: (2023-12-01) -
Uptake of the IMMPACT-recommended core outcome set in randomised controlled trials on chronic neck or shoulder pain: a cross-sectional study
by: Guoliang Li, et al.
Published: (2025-06-01) -
The effects of dipeptidyl peptidase-4 inhibitors on bone fracture among patients with type 2 diabetes mellitus: A network meta-analysis of randomized controlled trials.
by: Jun Yang, et al.
Published: (2017-01-01) -
Efficacy and Acceptability of Glycemic Control of Glucagon-Like Peptide-1 Receptor Agonists among Type 2 Diabetes: A Systematic Review and Network Meta-Analysis.
by: Zhixia Li, et al.
Published: (2016-01-01) -
Polyploid Induction Enhances Secondary Metabolite Biosynthesis in <i>Clausena lansium</i>: Morphological and Metabolomic Insights
by: Yu Ding, et al.
Published: (2025-07-01)